Innospec Valuation
Is 0JAX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0JAX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0JAX ($118.68) is trading above our estimate of fair value ($67.95)
Significantly Below Fair Value: 0JAX is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0JAX?
Key metric: As 0JAX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 0JAX's PE Ratio? | |
|---|---|
| PE Ratio | 20.8x |
| Earnings | US$143.80m |
| Market Cap | US$2.95b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 11.2x |
| PEG Ratio | 3x |
Price to Earnings Ratio vs Peers
How does 0JAX's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 25.4x | ||
JMAT Johnson Matthey | 23.8x | 28.4% | UK£2.6b |
CRDA Croda International | 30.4x | 15.1% | UK£4.9b |
VCT Victrex | 24.9x | 37.8% | UK£763.5m |
TET Treatt | 22.6x | 15.3% | UK£255.9m |
0JAX Innospec | 20.8x | 6.9% | US$3.0b |
Price-To-Earnings vs Peers: 0JAX is good value based on its Price-To-Earnings Ratio (20.8x) compared to the peer average (25.4x).
Price to Earnings Ratio vs Industry
How does 0JAX's PE Ratio compare vs other companies in the European Chemicals Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 0JAX is expensive based on its Price-To-Earnings Ratio (20.8x) compared to the European Chemicals industry average (16.8x).
Price to Earnings Ratio vs Fair Ratio
What is 0JAX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 20.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0JAX's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$118.68 | US$132.50 +11.6% | 5.7% | US$140.00 | US$125.00 | n/a | 2 |
| Nov ’25 | US$108.82 | US$128.50 +18.1% | 5.1% | US$135.00 | US$122.00 | n/a | 2 |
| Oct ’25 | US$111.23 | US$128.50 +15.5% | 5.1% | US$135.00 | US$122.00 | n/a | 2 |
| Sep ’25 | US$114.39 | US$128.50 +12.3% | 5.1% | US$135.00 | US$122.00 | n/a | 2 |
| Aug ’25 | US$125.97 | US$137.50 +9.2% | 5.5% | US$145.00 | US$130.00 | n/a | 2 |
| Jul ’25 | US$124.89 | US$137.50 +10.1% | 5.5% | US$145.00 | US$130.00 | n/a | 2 |
| Jun ’25 | US$127.77 | US$137.50 +7.6% | 5.5% | US$145.00 | US$130.00 | n/a | 2 |
| May ’25 | US$121.55 | US$132.50 +9.0% | 1.9% | US$135.00 | US$130.00 | n/a | 2 |
| Apr ’25 | US$129.02 | US$132.50 +2.7% | 1.9% | US$135.00 | US$130.00 | n/a | 2 |
| Mar ’25 | US$126.40 | US$127.00 +0.5% | 2.4% | US$130.00 | US$124.00 | n/a | 2 |
| Feb ’25 | US$118.20 | US$124.50 +5.3% | 0.4% | US$125.00 | US$124.00 | n/a | 2 |
| Jan ’25 | US$124.29 | US$124.50 +0.2% | 0.4% | US$125.00 | US$124.00 | n/a | 2 |
| Dec ’24 | n/a | US$124.50 0% | 0.4% | US$125.00 | US$124.00 | n/a | 2 |
| Nov ’24 | US$97.67 | US$123.50 +26.4% | 1.2% | US$125.00 | US$122.00 | US$108.82 | 2 |
| Oct ’24 | n/a | US$123.50 0% | 1.2% | US$125.00 | US$122.00 | US$111.23 | 2 |
| Sep ’24 | US$108.18 | US$123.50 +14.2% | 1.2% | US$125.00 | US$122.00 | US$114.39 | 2 |
| Aug ’24 | US$107.19 | US$123.50 +15.2% | 1.2% | US$125.00 | US$122.00 | US$125.97 | 2 |
| Jul ’24 | US$99.17 | US$123.50 +24.5% | 1.2% | US$125.00 | US$122.00 | US$124.89 | 2 |
| Jun ’24 | US$94.86 | US$123.50 +30.2% | 1.2% | US$125.00 | US$122.00 | US$127.77 | 2 |
| May ’24 | US$99.50 | US$123.50 +24.1% | 1.2% | US$125.00 | US$122.00 | US$121.55 | 2 |
| Apr ’24 | n/a | US$123.50 0% | 1.2% | US$125.00 | US$122.00 | US$129.02 | 2 |
| Mar ’24 | US$110.11 | US$123.50 +12.2% | 1.2% | US$125.00 | US$122.00 | US$126.40 | 2 |
| Feb ’24 | n/a | US$121.50 0% | 2.9% | US$125.00 | US$118.00 | US$118.20 | 2 |
| Jan ’24 | n/a | US$121.50 0% | 2.9% | US$125.00 | US$118.00 | US$124.29 | 2 |
| Dec ’23 | n/a | US$121.50 0% | 2.9% | US$125.00 | US$118.00 | n/a | 2 |
| Nov ’23 | n/a | US$117.50 0% | 6.4% | US$125.00 | US$110.00 | US$97.67 | 2 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Elkem
NOK 11.6b
Engages in the provision of advanced material solutions worldwide.
0SFN
NOK 18.10
7D
0.9%
1Y
-0.3%
Navigator Company
€2.5b
Manufactures and markets pulp and paper products worldwide.
0KLO
€3.52
7D
-2.9%
1Y
-7.0%
NV Bekaert
€1.7b
Provides steel wire transformation and coating technologies worldwide.
0OQJ
€32.44
7D
-0.6%
1Y
-22.0%